NCT05389423 2026-02-19Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting25 enrolled
NCT04305444 2025-01-08Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasZhejiang DTRM BiopharmaPhase 2 Terminated55 enrolled